Back

Proteomic profiling of extracellular vesicles in takotsubo syndrome

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies uncovered Experimental Heart Failure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Ermir Zulfaj

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

5 More presentations in this session

Presentation thumbnail
Fabry cardiomyopathy: myocardial fibrosis, inflammation and reduced mannose6phosphate receptors cause low accessibility to enzyme therapy.
Associate Professor A. Frustaci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Global and national insights into the decline of hypertrophic cardiomyopathy as a cause of sudden death in the young
Doctor D. Nelson (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients
Associate Professor C. Thonusin (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Clinical validated risk prediction model for development of heart failure after contemporary breast cancer treatment
Professor A. Barac (Fairfax, US)
Abstract Slides Video
Presentation thumbnail
Association of genetically predicted human metabolomic gene expression with incident heart failure
Mr H. Ahn (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies uncovered
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Coronary microvascular dysfunction in heart failure: observations from the MICRO registry
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources